Webinar · Palm Beach, Florida

How to Handle Corrections & Removals under 21 CFR 806

Health · Medicine · Pharmaceuticals

Next editionNot confirmedLast edition we have: 15 Jan 2015
Last venueOnlineWebinar
RunningSince 2015Frequency unknown · 1 edition on record
Last checked12 Nov 2026Its old website no longer answers
We haven't confirmed the next dates yet. The last edition in our records was 15 Jan 2015 at Webinar Venue. Its old website no longer answers, so the show may have ended or moved. Are you the organiser? Correct this listing.

Key numbers

Editions on record
1first in 2015

About How to Handle Corrections & Removals under 21 CFR 806

Overview:

As an experienced FDA medical device investigator, at one time or another many firms I’ve inspected have struggled with deciphering the definitions of the FDA regulations and misinterpret the definitions provided in §806.1 (a) (b)(1)(2)(3) that deal with exemptions are the most widely confused in interpretation and manufacturers and importers misinterpret reportability and documentation requirements required by § 806.10. Even if the firm does file a recall report within the specific timeframes, many times the firm fails to properly classify the recall.

When determining if a corrective action, market withdrawal or field service taken to a medical device in response to a design change or corrective action, the manufacturer must be sure to fully review the exemption requirements under §806.20 (j)- "Risk to health". Risk to health has two definitions, the first easily interpreted when there is a reasonable probability that the use or exposure of a medical device could cause serious adverse health consequences or death. Part 2 is confusing in that the definition states that a risk to health can be considered a temporary or medically reversible adverse health consequence or the possibility of serious adverse health consequences are remote.

Many manufacturers fail to properly classify their correction and removal based on severity. It is usually better to err on the side of caution and report the correction and removal; but in all cases, properly document the firm’s rationale for reporting or not reporting. Each year, the FDA emphasizes the need for investigators to determine that each firm under the FDA area of jurisdiction properly maintains "Recall SOPs", trains these procedures and fully implements them.

From our listing of this edition. Details may have changed since.

Editions

YearDatesWhereExhibitorsVisitors
201515 Jan 2015Webinar Venue
Online
——

Past editions from the bvents archive (2008–2019) and organiser figures where they were published.

Questions

When is How to Handle Corrections & Removals under 21 CFR 806?

The next dates haven't been confirmed. The last edition we have on record was 15 Jan 2015.

Where is it held?

The last edition we have was at Webinar Venue, Palm Beach, Florida.

Who organises it?

Compliance4All.

Industries